featured
Concordance of Plasma- and Tissue-Based cfDNA Analysis in Detecting Oncogenic Alterations in Advanced NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A large-scale prospective concordance study of plasma- and tissue-based next-generation targeted sequencing for advanced non-small cell lung cancer (LC-SCRUM-Liquid)
Clin. Cancer Res 2022 Oct 06;[EPub Ahead of Print], A Sugimoto, S Matsumoto, H Udagawa, R Itotani, Y Usui, S Umemura, K Nishino, I Nakachi, S Kuyama, H Daga, S Hara, S Miyamoto, T Kato, J Sakakibara-Konishi, E Tabata, T Nakagawa, T Kawaguchi, T Sakai, Y Shibata, H Izumi, K Nosaki, Y Zenke, K Yoh, K GotoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.